CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

Linda Wittkop(Université de Bordeaux), Elena Ferrer(Hospital Universitari Germans Trias i Pujol), Jürg Böni(University of Zurich), Charles Morrison(Family Health International 360), Ramón Teira(Hospital Sierrallana), Sophie Matheron(Assistance Publique – Hôpitaux de Paris), Rodolphe Thiébaut(Université de Bordeaux), Leah Shepherd(University College London), Jane Anderson(Baylor College of Medicine), Nina Friis‐Møller(University of Copenhagen), Julie Arsandaux(Université de Bordeaux), Dominique Costagliola(Inserm), Inmaculada Jarrín(Instituto de Salud Carlos III), Ard van Sighem(Stichting HIV Monitoring), François Dabis(Université de Bordeaux), Kholoud Porter(The Royal Free Hospital), Robert Zangerle(Universität Innsbruck), Vítor Duque(Universidade Federal de São Paulo), Ali Judd(PENTA Foundation), Alexandra Calmy(University Hospital of Geneva), Nikolaos V. Sipsas(National and Kapodistrian University of Athens), Faroudy Boufassa(Inserm), Emília Valadas(University of Lisbon), Maria Dorrucci, Norbert H. Brockmeyer(Deutsches Bergbau-Museum Bochum), Niels Obel(University of Copenhagen), Geneviève Chêne(Bordeaux Population Health), Olivier Lambotte(Inserm), Céline Colin(Université de Bordeaux), Ana Treviño(Instituto de Salud Carlos III), Catherine Leport(Université Paris Cité), Carlo Torti(Magna Graecia University), Gerd Fätkenheuer(University of Cologne), Cristina Mussini(University of Modena and Reggio Emilia), Anders Sönnerborg(Karolinska Institutet), C Schwarze-Zander(University Hospital Bonn), Jean Ruelle(University Colleges Leuven-Limburg), Françoise Brun‐Vézinet(Université Claude Bernard Lyon 1), Maarten Schim van der Loeff(Amsterdam UMC Location University of Amsterdam)
Journal of Antimicrobial Chemotherapy
June 6, 2017
Cited by 23


Related Papers